Serum Albumin–Lipid Membrane Interaction Influencing the Uptake of Porphyrins

2000 ◽  
Vol 373 (1) ◽  
pp. 261-270 ◽  
Author(s):  
Rita Galántai ◽  
Irén Bárdos-Nagy ◽  
Károly Módos ◽  
József Kardos ◽  
Péter Závodszky ◽  
...  
2017 ◽  
Vol 1859 (5) ◽  
pp. 803-812 ◽  
Author(s):  
Daniela Lopes ◽  
Cláudia Nunes ◽  
Philippe Fontaine ◽  
Bruno Sarmento ◽  
Salette Reis

Langmuir ◽  
2021 ◽  
Vol 37 (5) ◽  
pp. 1882-1893
Author(s):  
Neval Yilmaz ◽  
Yutaka Kodama ◽  
Keiji Numata

1996 ◽  
Vol 40 (12) ◽  
pp. 2865-2873 ◽  
Author(s):  
M Fresta ◽  
P M Furneri ◽  
E Mezzasalma ◽  
V M Nicolosi ◽  
G Puglisi

Dipalmitoylphosphatidylcholine vesicles were used as a biological membrane model to investigate the interaction and the permeation properties of trimethoprim and brodimoprim as a function of drug protonation. The drug-membrane interaction was studied by differential scanning calorimetry. Both drugs interacted with the hydrophilic phospholipid head groups when in a protonated form. An experiment on the permeation of the two drugs through dipalmitoylphosphatidylcholine biomembranes showed higher diffusion rate constants when the two drugs were in the uncharged form; lowering of the pH (formation of protonated species) caused a reduction of permeation. Drug uptake by human neutrophil cells was also investigated. Both drugs may accumulate within neutrophils; however, brodimoprim does so to a greater extent. This accumulation is probably due to a pH gradient driving force, which allows the two drugs to move easily from the extracellular medium (pH approximately 7.3) into the internal cell compartments (acid pH). Once protonated, both drugs are less able to permeate and can be trapped by the neutrophils. This investigation showed the importance of the physicochemical properties of brodimoprim and trimethoprim in determining drug accumulation and membrane permeation pathways.


2008 ◽  
Vol 366 (2) ◽  
pp. 500-505 ◽  
Author(s):  
Vitali Schewkunow ◽  
Karan P. Sharma ◽  
Gerold Diez ◽  
Anna H. Klemm ◽  
Pal C. Sharma ◽  
...  

Biomolecules ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 1067
Author(s):  
Christian Scheibe ◽  
Christiaan Karreman ◽  
Stefan Schildknecht ◽  
Marcel Leist ◽  
Karin Hauser

The 140 amino acid protein α-synuclein (αS) is an intrinsically disordered protein (IDP) with various roles and locations in healthy neurons that plays a key role in Parkinson’s disease (PD). Contact with biomembranes can lead to α-helical conformations, but can also act as s seeding event for aggregation and a predominant β-sheet conformation. In PD patients, αS is found to aggregate in various fibrillary structures, and the shift in aggregation and localization is associated with disease progression. Besides full-length αS, several related polypeptides are present in neurons. The role of many αS-related proteins in the aggregation of αS itself is not fully understood Two of these potential aggregation modifiers are the αS splicing variant αS Δexon3 (Δ3) and the paralog β-synuclein (βS). Here, polarized ATR-FTIR spectroscopy was used to study the membrane interaction of these proteins individually and in various combinations. The method allowed a continuous monitoring of both the lipid structure of biomimetic membranes and the aggregation state of αS and related proteins. The use of polarized light also revealed the orientation of secondary structure elements. While αS led to a destruction of the lipid membrane upon membrane-catalyzed aggregation, βS and Δ3 aggregated significantly less, and they did not harm the membrane. Moreover, the latter proteins reduced the membrane damage triggered by αS. There were no major differences in the membrane interaction for the different synuclein variants. In combination, these observations suggest that the formation of particular protein aggregates is the major driving force for αS-driven membrane damage. The misbalance of αS, βS, and Δ3 might therefore play a crucial role in neurodegenerative disease.


Soft Matter ◽  
2021 ◽  
Author(s):  
Xiaocong He ◽  
Lingxiao Li ◽  
Yuanyuan Yang ◽  
Zhaotong Dong ◽  
Lin Wang ◽  
...  

When nanoparticles (NPs) enter into the biological system, a wide range of proteins will coat on their surfaces forming protein corona, which changes the initial synthetic characteristics of NPs to...


2017 ◽  
Vol 37 (1) ◽  
Author(s):  
Hewen Li ◽  
Tao Zhao ◽  
Zhihua Sun

AbstractA better elucidation of molecular mechanisms underlying drug-membrane interaction is of great importance for drug research and development. To date, different biochemical and biophysical methods have been developed to study biological membranes at molecular level. This review focuses on the recent applications and achievements of modern analytical techniques in the study of drug interactions with lipid membranes, including chromatography, spectrometry, calorimetry, and acoustic sensing. The merits and limitations of these techniques were compared and critically discussed. Moreover, various types of biomimetic model membranes including liposomes, lipid monolayers, and supported lipid monolayers/bilayers were described. General mechanisms underlying drug-membrane interaction process were also briefly introduced.


Sign in / Sign up

Export Citation Format

Share Document